Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Harting, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 16 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mulken, O; Borrmann, P; Harting, J; Stamerjohanns, H
      Classification-of phase transitions of finite Bose-Einstein condensates inpower-law traps by Fisher zeros - art. no. 013611

      PHYSICAL REVIEW A
    2. Borrmann, P; Harting, J
      Order-disorder transition in nanoscopic semiconductor quantum rings

      PHYSICAL REVIEW LETTERS
    3. Harting, J; Mulken, O; Borrmann, P
      Interplay between shell effects and electron correlations in quantum dots

      PHYSICAL REVIEW B
    4. Borrmann, P; Mulken, O; Harting, J
      Classification of phase transitions in small systems

      PHYSICAL REVIEW LETTERS
    5. Matzen, L; van Amsterdam, C; Rautenberg, W; Greiner, HE; Harting, J; Seyfried, CA; Bottcher, H
      5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activity: A new approach toward efficient antidepressants

      JOURNAL OF MEDICINAL CHEMISTRY
    6. Mensonides-Harsema, MM; Liao, Y; Bottcher, H; Bartoszyk, GD; Greiner, HE; Harting, J; de Boer, P; Wikstrom, HV
      Synthesis and in vitro and in vivo functional studies of ortho-substitutedphenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635

      JOURNAL OF MEDICINAL CHEMISTRY
    7. Liao, Y; Bottcher, H; Harting, J; Greiner, H; van Amsterdam, C; Cremers, T; Sundell, S; Marz, J; Rautenberg, W; Wikstrom, H
      New selective and potent 5-HT1B/1D antagonists: Chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides

      JOURNAL OF MEDICINAL CHEMISTRY
    8. Borrmann, P; Harting, J; Mulken, O; Hilf, ER
      Calculation of thermodynamic properties of finite Bose-Einstein systems

      PHYSICAL REVIEW A
    9. Barber, A; Bender, HM; Gottschlich, R; Greiner, HE; Harting, J; Mauler, F; Seyfried, CA
      Effects of GR-89696 and the novel peripherally selective OP2 agonists, EMD-61569 and EMD-61747, against focal cerebral ischemia in the rat

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    10. Rupprecht, R; Koch, M; Montkowski, A; Lancel, M; Faulhaber, J; Harting, J; Spanagel, R
      Assessment of neuroleptic-like properties of progesterone

      PSYCHOPHARMACOLOGY
    11. BARTOSZYK GD; HARTING J; MINCK KO
      ROXINDOLE - PSYCHOPHARMACOLOGICAL PROFILE OF A DOPAMINE D-2 AUTORECEPTOR AGONIST

      The Journal of pharmacology and experimental therapeutics
    12. HOLZEMANN G; LOW A; HARTING J; GREINER HE
      CYCLIC HEXAPEPTIDE NK-2 ANTAGONISTS

      International journal of peptide & protein research
    13. JONKER JJC; VANBERGEN PFMM; VANDERMEER FJM; AZAR AJ; MEETER K; DECKERS JW; COLLY LP; TIJSSEN JGP; VANAKEN WG; DUNNING AJ; HOFMAN A; HUGENHOLTZ PG; VANDERKOOIJ S; LOELIGER EA; LUBSEN J; MEADE TW; VANDERMEER J; MIETTINEN OS; MITCHELL JRA; MUSTARD JF; PIETERS JJL; VANSTRIK R; VERHEUGT FWA; VERSTRAETE M; VIERSMA JW; VANZWIETEN PA; VANES GA; VANSTRIK P; VANZWIETEN PA; BECKER AE; VANDEBURGH PH; DEGRAEFF JJ; KOUDSTAAL PJ; MOLHOEK GP; DENEELING A; DENOTTOLANDER GJ; VANREES C; WINTZEN AR; ADMIRAAL J; ANTHEUNISSEN IM; BEINEMA MJ; VANBEUSEKOM WI; BOLWEGWAAGE MM; BREUKINKENGBERS WGM; BROEKMANS AW; CHIN H; VANDAM FE; VANDOMBURG RT; GERRITSDRABBE CW; VANGEESTDAALDEROP J; GEVENBOERE LM; HANNIVOORT EJW; HILLEN PH; HEERE FJ; HOLDRINET AC; JELETICHBASTIAANSE A; KIERS GJ; KOUSEMAKER AC; VANMEEGEN E; PIERSMA G; ROMMENS CAW; SCHAAP RC; VANDERVEUR E; VRIESGOLDSCHMEDING J; MEULENBELT F; VANDERBREDA BM; DUCHATEAU AMJA; ENGELBERTS P; BRENNINKMEYER VJ; DAGNEAUX PGLCK; VOS T; VERMEIJ P; BRANDENBURG HCR; DUIJNE C; GRAATSMA BH; LENDERINK AW; RUTTEN JJMH; HARTING J; SMITH TJ; VANDERVEEN D; VANDERBERGH D; DIJKSHOORN A; EIGENRAM P; DEJONG JD; KENSENHUIS IM; MAHLER CCE; VANDERSMAN AJ; VISSER HC; WIELDERS L; DEBEER YAJ; SPEELMAN M; OEI S
      EFFECT OF LONG-TERM ORAL ANTICOAGULANT TREATMENT ON MORTALITY AND CARDIOVASCULAR MORBIDITY AFTER MYOCARDIAL-INFARCTION

      Lancet
    14. BARBER A; BARTOSZYK GD; BENDER HM; GOTTSCHLICH R; GREINER HE; HARTING J; MAULER F; MINCK KO; MURRAY RD; SIMON M; SEYFRIED CA
      A PHARMACOLOGICAL PROFILE OF THE NOVEL, PERIPHERALLY-SELECTIVE KAPPA-OPIOID RECEPTOR AGONIST, EMD-61753

      British Journal of Pharmacology
    15. BARBER A; BARTOSZYK GD; GREINER HE; MAULER F; MURRAY RD; SEYFRIED CA; SIMON M; GOTTSCHLICH R; HARTING J; LUES I
      CENTRAL AND PERIPHERAL ACTIONS OF THE NOVEL KAPPA-OPIOID RECEPTOR AGONIST, EMD-60400

      British Journal of Pharmacology
    16. HOLZEMANN G; GREINER HE; HARTING J; BARNICKEL G; SEELIG A
      DO SUBSTANCE-P AGONISTS INSERT INTO THE LIPID-MEMBRANE

      Regulatory peptides


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 23:17:06